Drug evaluation and registration in Hungary.

Area of Science:

• Pharmaceutical Regulation
• Drug Approval Processes
• Public Health Policy

Background:

• Hungary's drug registration system, established in 1933, aligns with international standards and national practices.
• Key components include laboratory control (since 1927), clinical trials (since 1951), and human clinical pharmaceutical experiments (since 1967).

Purpose of the Study:

• To detail Hungary's comprehensive drug evaluation and registration system.
• To highlight the rigorous steps required for new drug approval.

Main Methods:

• Submission of applications to the National Institute of Pharmacy for assessment of quality, safety, and efficacy.
• Multi-step evaluation involving chemical, pharmaceutical, toxicologic, and pharmacologic data.
• Mandatory ethical review and authorized clinical investigations through a national network.

Main Results:

• A structured, multi-phase process ensures drug approval based on scientific evaluation.
• Procedures can be expedited for drugs already registered internationally.
• Hungary actively participates in global pharmaceutical collaborations.

Conclusions:

• Hungary possesses a robust and long-standing drug registration system.
• The system integrates international best practices with national requirements.
• Active international engagement facilitates pharmaceutical trade and collaboration.